These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15878709)

  • 1. Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).
    Phelps PT; Anthes JC; Correll CC
    Eur J Pharmacol; 2005 Apr; 513(1-2):57-66. PubMed ID: 15878709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and pharmacological characterization of mouse TRPV1.
    Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S
    Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1.
    Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S
    Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of vanilloid sensitivity in TRPV1.
    Gavva NR; Klionsky L; Qu Y; Shi L; Tamir R; Edenson S; Zhang TJ; Viswanadhan VN; Toth A; Pearce LV; Vanderah TW; Porreca F; Blumberg PM; Lile J; Sun Y; Wild K; Louis JC; Treanor JJ
    J Biol Chem; 2004 May; 279(19):20283-95. PubMed ID: 14996838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.
    Valenzano KJ; Grant ER; Wu G; Hachicha M; Schmid L; Tafesse L; Sun Q; Rotshteyn Y; Francis J; Limberis J; Malik S; Whittemore ER; Hodges D
    J Pharmacol Exp Ther; 2003 Jul; 306(1):377-86. PubMed ID: 12721338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat.
    Bölcskei K; Tékus V; Dézsi L; Szolcsányi J; Petho G
    Eur J Pain; 2010 May; 14(5):480-6. PubMed ID: 19800272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.
    Gavva NR; Tamir R; Klionsky L; Norman MH; Louis JC; Wild KD; Treanor JJ
    Mol Pharmacol; 2005 Dec; 68(6):1524-33. PubMed ID: 16135784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
    De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.
    Spicarova D; Palecek J
    J Neurophysiol; 2009 Jul; 102(1):234-43. PubMed ID: 19369364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of species-specific determinants of the action of the antagonist capsazepine and the agonist PPAHV on TRPV1.
    Phillips E; Reeve A; Bevan S; McIntyre P
    J Biol Chem; 2004 Apr; 279(17):17165-72. PubMed ID: 14960593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct evidence for activation and desensitization of the capsaicin receptor by N-oleoyldopamine on TRPV1-transfected cell, line in gene deleted mice and in the rat.
    Szolcsányi J; Sándor Z; Petho G; Varga A; Bölcskei K; Almási R; Riedl Z; Hajos G; Czéh G
    Neurosci Lett; 2004 May; 361(1-3):155-8. PubMed ID: 15135917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
    Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
    Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular identification and functional characterization of a temperature-sensitive transient receptor potential channel (TRPM8) from canine.
    Liu Y; Lubin ML; Reitz TL; Wang Y; Colburn RW; Flores CM; Qin N
    Eur J Pharmacol; 2006 Jan; 530(1-2):23-32. PubMed ID: 16386244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservation of functional and pharmacological properties in the distantly related temperature sensors TRVP1 and TRPM8.
    Weil A; Moore SE; Waite NJ; Randall A; Gunthorpe MJ
    Mol Pharmacol; 2005 Aug; 68(2):518-27. PubMed ID: 15911692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional study on TRPV1-mediated signalling in the mouse small intestine: involvement of tachykinin receptors.
    de Man JG; Boeckx S; Anguille S; de Winter BY; de Schepper HU; Herman AG; Pelckmans PA
    Neurogastroenterol Motil; 2008 May; 20(5):546-56. PubMed ID: 18194153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain.
    Pomonis JD; Harrison JE; Mark L; Bristol DR; Valenzano KJ; Walker K
    J Pharmacol Exp Ther; 2003 Jul; 306(1):387-93. PubMed ID: 12721336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists.
    Appendino G; Harrison S; De Petrocellis L; Daddario N; Bianchi F; Schiano Moriello A; Trevisani M; Benvenuti F; Geppetti P; Di Marzo V
    Br J Pharmacol; 2003 Aug; 139(8):1417-24. PubMed ID: 12922928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPV3 is a temperature-sensitive vanilloid receptor-like protein.
    Smith GD; Gunthorpe MJ; Kelsell RE; Hayes PD; Reilly P; Facer P; Wright JE; Jerman JC; Walhin JP; Ooi L; Egerton J; Charles KJ; Smart D; Randall AD; Anand P; Davis JB
    Nature; 2002 Jul; 418(6894):186-90. PubMed ID: 12077606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin.
    Seabrook GR; Sutton KG; Jarolimek W; Hollingworth GJ; Teague S; Webb J; Clark N; Boyce S; Kerby J; Ali Z; Chou M; Middleton R; Kaczorowski G; Jones AB
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1052-60. PubMed ID: 12438527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization using FLIPR of rat vanilloid receptor (rVR1) pharmacology.
    Jerman JC; Brough SJ; Prinjha R; Harries MH; Davis JB; Smart D
    Br J Pharmacol; 2000 Jun; 130(4):916-22. PubMed ID: 10864900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.